AU7370894A - Method of inhibiting the production of human immunodeficiency viruses with substituted azaspiranes - Google Patents

Method of inhibiting the production of human immunodeficiency viruses with substituted azaspiranes

Info

Publication number
AU7370894A
AU7370894A AU73708/94A AU7370894A AU7370894A AU 7370894 A AU7370894 A AU 7370894A AU 73708/94 A AU73708/94 A AU 73708/94A AU 7370894 A AU7370894 A AU 7370894A AU 7370894 A AU7370894 A AU 7370894A
Authority
AU
Australia
Prior art keywords
compound
formula
hiv
inhibiting
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73708/94A
Other languages
English (en)
Inventor
Alison Mary Badger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU7370894A publication Critical patent/AU7370894A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU73708/94A 1993-07-23 1994-07-22 Method of inhibiting the production of human immunodeficiency viruses with substituted azaspiranes Abandoned AU7370894A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939315306A GB9315306D0 (en) 1993-07-23 1993-07-23 Methods
GB9315306 1993-07-23
PCT/US1994/008275 WO1995003041A1 (fr) 1993-07-23 1994-07-22 Procede d'inhibition de la production de virus de l'immunodeficience chez l'homme au moyen d'azaspiranes substitues

Publications (1)

Publication Number Publication Date
AU7370894A true AU7370894A (en) 1995-02-20

Family

ID=10739328

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73708/94A Abandoned AU7370894A (en) 1993-07-23 1994-07-22 Method of inhibiting the production of human immunodeficiency viruses with substituted azaspiranes

Country Status (8)

Country Link
EP (1) EP0713391A4 (fr)
CN (1) CN1130870A (fr)
AU (1) AU7370894A (fr)
CA (1) CA2167841A1 (fr)
GB (1) GB9315306D0 (fr)
NZ (1) NZ269990A (fr)
WO (1) WO1995003041A1 (fr)
ZA (1) ZA945416B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9315340D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315351D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
BR9601909A (pt) * 1995-07-13 1999-10-13 Smithkline Beecham Corp N,n-dietil-8,8-dipropil-2-azaspiro(4,5)decano-2-propan amina dimaleato
SK156698A3 (en) * 1996-05-17 1999-06-11 Anormed Inc Use of substituted azaspirane in the treatment of asthma
TW574036B (en) 1998-09-11 2004-02-01 Elan Pharm Inc Stable liquid compositions of botulinum toxin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes
ZA921120B (en) * 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors
GB9201803D0 (en) * 1992-01-28 1992-03-11 Smithkline Beecham Corp Methods
GB9201804D0 (en) * 1992-01-28 1992-03-11 Smithkline Beecham Corp Methods
GB9315340D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315351D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315271D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods

Also Published As

Publication number Publication date
CN1130870A (zh) 1996-09-11
NZ269990A (en) 1999-07-29
ZA945416B (en) 1995-05-10
EP0713391A1 (fr) 1996-05-29
GB9315306D0 (en) 1993-09-08
EP0713391A4 (fr) 1998-09-09
CA2167841A1 (fr) 1995-02-02
WO1995003041A1 (fr) 1995-02-02

Similar Documents

Publication Publication Date Title
DK164441B (da) Anvendelse af et piperidinderivat til fremstilling af et farmaceutisk praeparat til behandling af smertetilstande
UA81003C2 (en) Use of a combination containing a non-nucleoside reverse transcriptase inhibitor (nnrti) with an inhibitor of cytochrome p450
AU7370894A (en) Method of inhibiting the production of human immunodeficiency viruses with substituted azaspiranes
AU7370994A (en) Method of inhibiting the replication of human immunodeficiency viruses with substituted azaspiranes
US5482959A (en) Method for delaying aids in an HIV infected individual by administration of substituted azaspirane compounds
EP0717622A1 (fr) Procedes de traitement du vih au moyen d'azaspiranes
AU3595193A (en) A method for delaying HIV induced AIDS by administration of substituted azasperane compounds
AU710542B2 (en) Use of substituted azaspirane in the treatment of asthma
AU684384B2 (en) Method of treating opportunistic infections with azaspiranes
US5786376A (en) Methods of treating opportunistic infections with azaspiranes
WO2020237096A1 (fr) Combinaison pour baisser le phosphate sérique chez un patient
EP0996445A1 (fr) Traitement et prevention de maladies cardiaques au moyen d'inhibiteurs specifiques du recaptage de la serotonine (ssri)
JPH09500647A (ja) 置換アザスピランによるヒト免疫不全ウイルス産生の阻害法
MXPA98009596A (en) Use of azaspiran substituted in the treatment of a
WO1995003048A1 (fr) Azaspiranes anti-hiv
WO1995003046A1 (fr) Procede d'inhibition de la production de vih
WO1995003047A1 (fr) Traitements s'exercant contre le virus de l'immunodeficience chez l'homme
JPS6231682B2 (fr)